EP
CRBU icon

Essential Partners’s Caribou Biosciences CRBU Stock Holding History

Essential Partners’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-157
Closed -$366 – 2805
2025
Q3 		$366 Sell
157
-724
-82% -$1.37K ﹤0.01% 2277
2025
Q2 		$1.11K Buy
+881
New +$866 ﹤0.01% 1486

Other funds holding CRBU

P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Essential Partners's CRBU Position: Q4 2025 in Review

Essential Partners sold out of Caribou Biosciences (CRBU) in Q4 2025, closing a stake of 157 shares — an estimated $366 sold.

Essential Partners first reported a position in CRBU in Q2 2025 and held it in 2 quarters. The position peaked at $1.11K in Q2 2025. 124 funds tracked by Wall St. Rank hold CRBU as of Q4 2025.

  • Essential Partners reported no remaining Caribou Biosciences position as of Q4 2025 after selling out during the quarter.
  • Essential Partners sold 157 Caribou Biosciences shares in Q4 2025, an estimated $366.
  • Essential Partners first reported a position in Caribou Biosciences in Q2 2025 and held it in 2 quarters.
  • Essential Partners's Caribou Biosciences position peaked at $1.11K in Q2 2025.
  • 124 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2025.

Based on Essential Partners's 13F filing for Q4 2025, filed 21 May 2026.